|
WO2020056249A1
|
|
Oral formulations of kappa opioid receptor agonists
|
|
US2018078605A1
|
|
Peripheral kappa opioid receptor agonists for uremic pruritus in dialysis patients
|
|
US2017007574A1
|
|
Peripheral kappa opioid receptor agonists for uremic pruritus in dialysis patients
|
|
WO2016073443A2
|
|
Peripheral kappa opioid receptor agonists for hard tissue pain
|
|
US2015152138A1
|
|
Uses of kappa opioid synthetic peptide amides
|
|
US2016250277A1
|
|
Peripheral kappa opioid receptor agonists for preventing, inhibiting or treating nausea and vomiting
|
|
US2015150935A1
|
|
Peripheral kappa receptor agonists for reducing pain and inflammation
|
|
ZA201000435B
|
|
Substituted imidazoheterocycles
|
|
KR20110106450A
|
|
Bicyclic pyrazolo-heterocycles
|
|
WO2010068520A2
|
|
Substituted imidazoheterocycle derivatives
|
|
US7741350B1
|
|
Bicyclic pyrazolo-heterocycles
|
|
US2011190336A1
|
|
Azabenzimidazolones
|
|
WO2009120660A2
|
|
Substituted pyridoxazines
|
|
US2010105777A1
|
|
Amide or thioamide derivatives and their use in the treatment of pain
|
|
US2009075973A1
|
|
Benzo-fused heterocycles
|
|
MY146924A
|
|
Substituted imidazoheterocycles
|
|
US2009156508A1
|
|
Synthetic peptide amides and dimeric forms thereof
|
|
US2008214537A1
|
|
Bridged phenanthridines
|
|
US2008161340A1
|
|
Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof
|
|
MY153678A
|
|
Synthetic peptide amides and dimers thereof
|
